As per Tuesday, October 10, the company rating was maintained by Stifel Nicolaus. The stock of Southwestern Energy Company (NYSE:SWN) earned "Buy" rating by Suntrust Robinson on Thursday, September 10. The stock decreased 1.96% or $0.125 during the last trading session, reaching $6.255. About 19.56 million shares traded or 21.56% up from the average. It has underperformed by 57.70% the S&P500.
Southwestern Energy Company on 9/29/2017 reported its EPS as $0.08 with the analysts projecting the EPS of the stock as $0.12. They expect $0.16 EPS, up 100.00% or $0.08 from last year's $0.08 per share. For the past 5 years, the company's revenue has grown 0%, while the company's earnings per share has grown 0%.
According to 31 analysts, the Average Revenue Estimate for the current Fiscal quarter is $2.61 Billion and the Low Revenue estimate is $2.59 Billion, while the High Revenue estimate is $2.64 Billion. Taking a look at historical stock price data, we have noted that over the last 52-week period the high price is 12.61. The average twelve-month target price among analysts that have updated their coverage on the stock in the a year ago is $11.05. The original version of this news story can be read at https://www.thelincolnianonline.com/2017/12/01/43219-shares-in-southwestern-energy-company-swn-acquired-by-crossmark-global-holdings-inc.html. Cowen & Co initiated Southwestern Energy Company (NYSE:SWN) on Tuesday, July 21 with "Outperform" rating. The rating was maintained by Morgan Stanley on Wednesday, October 18 with "Underweight". The company was maintained on Thursday, July 13 by Piper Jaffray. The firm earned "Neutral" rating on Monday, September 18 by PiperJaffray.
This movement could be bad/good signal for few investors as firm is showing performance for the quarter as -0.75%. The portion of a company's profit allocated to each outstanding share of common stock was $0.62 a share in the trailing twelve months.
More important recent Southwestern Energy Company (NYSE:SWN) news were published by: Prnewswire.com which released: "Southwestern Energy Appoints Clayton Carrell As Chief Operating Officer" on December 04, 2017, also Nasdaq.com published article titled: "Is Southwestern Energy (SWN) a Good Pick for Value Investors?", Prnewswire.com published: "Southwestern Energy Announces Receipt Of Requisite Consents In Its Consent ..." on November 29, 2017. 61 funds opened positions while 125 raised stakes. Grantham Mayo Van Otterloo Comm Limited Liability Co invested in 0% or 105,283 shares. Cibc Asset Mngmt accumulated 0% or 12,661 shares. Stephens Ar owns 0.01% invested in Southwestern Energy Company (NYSE:SWN) for 44,014 shares.
Hodges Capital Management Inc. holds 0.44% of its portfolio in Shoe Carnival, Inc. for 354,049 shares. North Star Invest Management Corp holds 11,475 shares.
Southwestern Energy Company (SWN)'s RSI (Relative strength index) is at 47.39, its ATR (Average True Range) value is 0.29, while its Beta factor was calculated at 1.24.
Looking forward, the company's quarterly earnings are expected to come at $0.14 in the three months through December 2017 and $0.27 in the quarter ending March 2018, reflecting 75% and 50% growth, respectively. Ally Financial holds 215,000 shares. Manufacturers Life Insurance Co The has 743,198 shares. 182 were reported by Parkside Bancshares & Tru.
Houlihan Lokey, Inc., an investment banking company, provides mergers and acquisitions, financings, financial restructurings, and financial advisory services in the United States, Canada, Europe, Asia, Australia, the Middle East, Latin America, and Africa. The correct version of this article can be accessed at https://www.truebluetribune.com/2017/12/06/southwestern-energy-company-swn-shares-bought-by-castleton-investment-management-llc.html. 3,400,600 shares of the company's stock traded hands, compared to its average volume of 3,786,234. SWN's SI was 42.50 million shares in December as released by FINRA.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases.
The SMA200 of the stock is at -3.48%, SMA20 is -1.09%, while SMA50 is 4.13%. For long term intention long timeframe can help for decision for this quarter, semi-annual and annual performance measures are more useful. It has a 23.27 P/E ratio.